New Delhi : Diagnostic chain Dr Lal PathLabs raised over Rs 191 crore from anchor investors by selling shares at a price of Rs 550 apiece. The company’s initial public offer aims to raise up to Rs 638 crore.
Price band for the offer has been fixed at Rs 540-550 per share and the allotment to anchor investors has been done at the higher end.
At the price of Rs 550 apiece, the company would mop up Rs 191.40 crore from the anchor investors, including Reliance Life Insurance and Birla SunLife.
Mumbai Local Train Update: Central Railway Announces Mega Block On July 13 Affecting Thane–Vidyavihar & Kurla–Vashi Routes
Controversy Erupts After Bengal University Exam Paper Labels Freedom Fighters As ‘Terrorists’; Vice-Chancellor Issues Apology
'Non-Hindus Must Be Removed From TTD Jobs Immediately': Union Minister Bandi Sanjay Kumar
‘My Favourite Is Panki, What About You?’: Japanese Ambassador Relishes Gujarati Food During His State Visit; Netizens React
